Leronlimab binds to the N terminus and the second
Post# of 148112
With narsoplimab it blocks the complement activation pathway that can induce a cytokine storm but leaves the classical (much stronger) and alternative pathway for the cytokine storm to develop. Leronlimab blocking the chemokines takes care of all three pathways.